Evidence map›Paper›PMID 41053117›Full record

ArticleCell death & disease2025

ALIX mediates reversible gasdermin-D pore formation via the endosomal pathway to limit pyroptosis by active membrane repair.

Sylvia Otchere, Prafulla Shrestha, Himesh N Parmar, Jadyn F Perry, Brittany L Hofmeister, Michelle Steyn, Radhey S Kaushik, Adam D Hoppe, Natalie W Thiex, Ryan L Hanson and 2 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Caspase-1 in cancer and inflammatory diseases: a potential therapeutic target.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sylvia OtchereDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.ORCID http://orcid.org/0009-0005-9609-7365
Prafulla ShresthaDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.ORCID http://orcid.org/0009-0005-6034-2058
Himesh N ParmarDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Jadyn F PerryDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Brittany L HofmeisterDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Michelle SteynDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Radhey S KaushikDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Adam D HoppeDepartment of Chemistry, Biochemistry, and Physics, South Dakota State University, Brookings, SD, USA.
Natalie W ThiexDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Ryan L HansonDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA.
Jaime Lopez-MosquedaDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Gergely ImreDepartment of Biology and Microbiology, South Dakota State University, Brookings, SD, USA. gergely.imre@sdstate.edu.ORCID http://orcid.org/0000-0003-2474-0524

Funding

Transcriptome & Networks Analysis CoreP20GM135008 · NIGMS · SOUTH DAKOTA STATE UNIVERSITY · PI Adam David Hoppe · 2022 to 2026
$13.5M
LUBAC-dependent regulation of cell deathR01GM138861 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI LOPEZ-MOSQUEDA, JAIME · 2021 to 2025
$1.4M
NIGMS NIH HHS P20 GM135008NIGMS NIH HHS R01 GM138861U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) P20GM135008
6 · The paper itself

Abstract

Pyroptosis is a form of regulatory cell death characterized by membrane rupture and release of pro-inflammatory signals. In pyroptosis, Caspase-1 activation leads to the cleavage of gasdermin-D (GSDMD). Upon cleavage, GSDMD's N-terminal (N-GSDMD) fragments insert into the plasma membrane, oligomerize, and form pores. The molecular details that define whether GSDMD pore formation results in cell death or survival are largely unknown. In this study, we show that a shorter duration of membrane N-GSDMD pores (t ≤ 2 h), along with associated membrane permeability does not harm cellular viability. We demonstrate that N-GSDMD is removed, and membrane integrity is restored if the pyroptotic stimulus is washed out within 1 hour. In contrast, longer duration of N-GSDMD pore formation leads to large-scale membrane damage and cell death. Using a selective dynamin inhibitor and confocal microscopy, to co-label N-terminal GSDMD (N-GSDMD) and the early endosomal marker EEA1, we demonstrate that N-GSDMD is cleared from the plasma membrane via the endosomal pathway. Through stable ALIX knockdown and overexpression approaches, we further show that ALIX, a key accessory protein of the ESCRT machinery, regulates N-GSDMD pore dynamics by promoting its removal and facilitating membrane repair via N-GSDMD internalization. In summary, we show that the duration of N-GSDMD membrane pores is a decisive factor and ALIX-dependent mechanism facilitates N-GSDMD removal and restores membrane integrity. The identification of these factors can open the development of new therapeutic strategies in chronic inflammatory conditions by bolstering the cell's inherent self-healing potential.

Indexed as

Cell MembraneEndosomal Sorting Complexes Required for TransportEndosomesIntracellular Signaling Peptides and ProteinsNeoplasm ProteinsPhosphate-Binding ProteinsPyroptosisGasderminsHumansEndosomal Sorting Complexes Required for TransportGasderminsGSDMD protein, humanIntracellular Signaling Peptides and ProteinsNeoplasm ProteinsPhosphate-Binding Proteins

Identifiers

PMID41053117
PMCPMC12501301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.